Thus, the expression levels of the eight RBPs (DDX24, CBFA2T2, NOP14, ILF3, DNMT1, FTO, PPRC1, and NOLC1) were altered in the patients with sepsis might potentially be useful as novel biomarkers as well as targets to facilitate the diagnosis and management of sepsis. The gene discussed is FTO; the disease is Sepsis.